These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 38385427)

  • 41. Influence of everolimus on the pharmacokinetics of tacrolimus in Japanese renal transplant patients.
    Niioka T; Kagaya H; Saito M; Inoue T; Numakura K; Yamamoto R; Akamine Y; Habuchi T; Satoh S; Miura M
    Int J Urol; 2016 Jun; 23(6):484-90. PubMed ID: 26990259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. De novo Prograf versus de novo Advagraf: are trough level profile curves similar?
    Sarvary E; Wagner L; Telkes G; Gaman G; Varga M; Gaal I; Mathe Z; Chmel R; Fehervari I; Langer RM
    Transplant Proc; 2014; 46(6):2164-7. PubMed ID: 25131131
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience.
    Rhu J; Lee KW; Park H; Park JB; Kim SJ; Choi GS
    Ann Transplant; 2017 Nov; 22():707-718. PubMed ID: 29180612
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report.
    Scherkl C; Meid AD; Cuntz SE; Classen L; Weiss J; Czock D; Haefeli WE
    Pharmacol Res Perspect; 2024 Jun; 12(3):e1198. PubMed ID: 38635290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lansoprazole-tacrolimus interaction in Japanese transplant recipient with CYP2C19 polymorphism.
    Takahashi K; Motohashi H; Yonezawa A; Okuda M; Ito N; Yamamoto S; Ogawa O; Inui K
    Ann Pharmacother; 2004 May; 38(5):791-4. PubMed ID: 15010519
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Interaction between sildenafil and calcineurin inhibitors in renal transplant recipients with erectile dysfunction].
    Cofán F; Gutiérrez R; Beardo P; Campistol JM; Oppenheimer F; Alcover J
    Nefrologia; 2002; 22(5):470-6. PubMed ID: 12497749
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adding sirolimus to tacrolimus-based immunosuppression in pediatric renal transplant recipients reduces tacrolimus exposure.
    Filler G; Womiloju T; Feber J; Lepage N; Christians U
    Am J Transplant; 2005 Aug; 5(8):2005-10. PubMed ID: 15996252
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of Prolonged-Release Once-Daily Formulations of Tacrolimus in De Novo Kidney Transplant Recipients: A Randomized, Parallel-Group, Open-Label, Multicenter Study.
    Kamar N; Cassuto E; Piotti G; Govoni M; Ciurlia G; Geraci S; Poli G; Nicolini G; Mariat C; Essig M; Malvezzi P; Le Meur Y; Garrigue V; Del Bello A; Rostaing L
    Adv Ther; 2019 Feb; 36(2):462-477. PubMed ID: 30552587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.
    Peng ZG; Tian J
    Clin Transpl; 2014; ():209-14. PubMed ID: 26281147
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tacrolimus interaction with oral oestrogen in kidney transplant recipients: A case-control study.
    Ghadimi M; Dashti-Khavidaki S; Shahali M; Gohari M; Khatami MR; Alamdari A
    J Clin Pharm Ther; 2018 Aug; 43(4):513-518. PubMed ID: 29492991
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of antifungal drugs on the plasma concentrations and dosage of tacrolimus in kidney transplant patients.
    Cheng S; Tang M; Du J; Yin T
    Eur J Hosp Pharm; 2022 Jul; 29(4):202-206. PubMed ID: 33020057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacokinetics of tacrolimus in rescue therapy after renal transplantation.
    Budde K; Fritsche L; Mai I; Bauer S; Smettan S; Waiser J; Hofmann T; Hauser I; Reinke P; Neumayer HH
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):493-7. PubMed ID: 8937932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients.
    Kuypers DR; de Jonge H; Naesens M; Vanrenterghem Y
    Pharmacogenet Genomics; 2008 Oct; 18(10):861-8. PubMed ID: 18704002
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kidney Transplant in a Human Immunodeficiency Virus-Positive Patient: Case Report of Drug Interactions.
    Yılmaz M; Gökengin D; Bozbıyık O; Hoşcoşkun C; Uyan A; Töz H
    Exp Clin Transplant; 2023 Apr; 21(4):365-367. PubMed ID: 28969531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of the drug interaction between intravenous high-dose fluconazole and cyclosporine or tacrolimus in bone marrow transplant patients.
    Osowski CL; Dix SP; Lin LS; Mullins RE; Geller RB; Wingard JR
    Transplantation; 1996 Apr; 61(8):1268-72. PubMed ID: 8610430
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modeling of Tacrolimus Exposure in Kidney Transplant According to Posttransplant Time Based on Routine Trough Concentration Data.
    Ben Fredj N; Woillard JB; Debord J; Chaabane A; Boughattas N; Marquet P; Saint-Marcoux F; Aouam K
    Exp Clin Transplant; 2016 Aug; 14(4):394-400. PubMed ID: 27506258
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tacrolimus trough and dose intra-patient variability and CYP3A5 genotype: Effects on acute rejection and graft failure in European American and African American kidney transplant recipients.
    Seibert SR; Schladt DP; Wu B; Guan W; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
    Clin Transplant; 2018 Dec; 32(12):e13424. PubMed ID: 30318646
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic equivalence and pharmacokinetics of generic tacrolimus formulation in de novo kidney transplant patients.
    Min SI; Ha J; Kim YS; Ahn SH; Park T; Park DD; Kim SM; Min SK; Hong H; Ahn C; Kim SJ
    Nephrol Dial Transplant; 2013 Dec; 28(12):3110-9. PubMed ID: 24084327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
    Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
    Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.